TW214553B - - Google Patents

Download PDF

Info

Publication number
TW214553B
TW214553B TW081102729A TW81102729A TW214553B TW 214553 B TW214553 B TW 214553B TW 081102729 A TW081102729 A TW 081102729A TW 81102729 A TW81102729 A TW 81102729A TW 214553 B TW214553 B TW 214553B
Authority
TW
Taiwan
Prior art keywords
compound
formula
temperature
ministry
range
Prior art date
Application number
TW081102729A
Other languages
English (en)
Chinese (zh)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of TW214553B publication Critical patent/TW214553B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW081102729A 1991-04-11 1992-04-09 TW214553B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68377091A 1991-04-11 1991-04-11

Publications (1)

Publication Number Publication Date
TW214553B true TW214553B (cg-RX-API-DMAC7.html) 1993-10-11

Family

ID=24745378

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081102729A TW214553B (cg-RX-API-DMAC7.html) 1991-04-11 1992-04-09

Country Status (14)

Country Link
EP (2) EP0508792A1 (cg-RX-API-DMAC7.html)
JP (1) JPH06503837A (cg-RX-API-DMAC7.html)
CA (1) CA2108146A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ213693A3 (cg-RX-API-DMAC7.html)
FI (1) FI934461A0 (cg-RX-API-DMAC7.html)
HU (1) HUT70187A (cg-RX-API-DMAC7.html)
IE (1) IE921148A1 (cg-RX-API-DMAC7.html)
IL (1) IL101554A0 (cg-RX-API-DMAC7.html)
MX (1) MX9201643A (cg-RX-API-DMAC7.html)
NO (1) NO933611L (cg-RX-API-DMAC7.html)
NZ (1) NZ242294A (cg-RX-API-DMAC7.html)
SK (1) SK108293A3 (cg-RX-API-DMAC7.html)
TW (1) TW214553B (cg-RX-API-DMAC7.html)
WO (1) WO1992018507A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
EP0575955B1 (en) * 1992-06-22 1999-09-15 Kyowa Hakko Kogyo Co., Ltd. Process for producing staurosporine derivatives
AU5100393A (en) * 1992-09-25 1994-04-26 Schering Corporation Diindolo compounds and pharmaceutical compositions containing them
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
PE49195A1 (es) * 1993-12-07 1996-01-06 Lilly Co Eli Inhibidor de proteinquinasa
WO1995022331A1 (en) * 1994-02-18 1995-08-24 Cephalon, Inc. Aqueous indolocarbazole solutions
AU6657596A (en) * 1995-07-31 1997-02-26 Ciba-Geigy Ag Trindene compounds
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
FR2826653B1 (fr) * 2001-06-29 2005-10-14 Servier Lab Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TWI335221B (en) 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
DK1651161T3 (da) 2003-08-07 2012-01-30 Healor Ltd Farmaceutiske præparater og fremgangsmåder til at fremme sårheling
EP1940440A4 (en) 2005-08-29 2009-11-11 Healor Ltd METHOD AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETIC AND AGED SKIN
EP2181999A1 (en) 2008-11-03 2010-05-05 Zentiva, A.S. Method of manufacturing ruboxistarin
AU2011204425A1 (en) 2010-01-11 2012-08-02 Healor Ltd. Method for treatment of inflammatory disease and disorder
JP2017524739A (ja) 2014-07-17 2017-08-31 アンセルムＩｎｓｅｒｍ 神経筋接合部関連疾患の処置方法
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303697B1 (en) * 1987-03-09 1997-10-01 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance k-252
DE3924538A1 (de) * 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung

Also Published As

Publication number Publication date
NO933611D0 (no) 1993-10-08
FI934461A7 (fi) 1993-10-11
MX9201643A (es) 1992-10-01
NO933611L (no) 1993-10-08
NZ242294A (en) 1993-07-27
AU646163B2 (en) 1994-02-10
IL101554A0 (en) 1992-12-30
EP0580812A1 (en) 1994-02-02
WO1992018507A1 (en) 1992-10-29
EP0508792A1 (en) 1992-10-14
IE921148A1 (en) 1992-10-21
HU9302869D0 (en) 1993-12-28
AU1798292A (en) 1992-11-17
FI934461L (fi) 1993-10-11
SK108293A3 (en) 1994-09-07
JPH06503837A (ja) 1994-04-28
CA2108146A1 (en) 1992-10-12
FI934461A0 (fi) 1993-10-11
CZ213693A3 (en) 1994-05-18
HUT70187A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
TW214553B (cg-RX-API-DMAC7.html)
JPS6183198A (ja) 新規アミノ酸化合物
US20250115555A1 (en) Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide
JPS6317882A (ja) ５−置換−１Ｈ−ピラゾロ〔３，４−ｂ〕ピラジン誘導体及び該化合物を含有する抗腫瘍剤
CN111423438B (zh) 具有抗肿瘤活性的Eudistomins Y类衍生物及其制备方法和应用
CN104557588B (zh) 咖啡酸和阿魏酸的同二聚体,其制备方法及其药物组合物
DE69707098T2 (de) Substituierte tetralylmethylenoxindol-analoga als tyrosinkinase-inhibitoren
CN101296694A (zh) 药物镓组合物和方法
JPH0253795A (ja) 新規なエステル
JP2022553833A (ja) エストロゲン受容体調節薬の塩及び形態
CN106065016A (zh) 一种周期素依赖性蛋白激酶抑制剂的结晶形式及其制备方法
CN104327053A (zh) 氘代克里唑蒂尼及其衍生物、制备方法及应用
JPS6242953A (ja) １，１，２，２−テトラメチル−１，２−ビス−（フツ素−４−ヒドロキシ−フエニル）−エタンの新規誘導体、その製法およびこれを含有する抗癌剤
WO2023193563A1 (zh) 一种噻吩并吡啶化合物的晶型a、制备方法及其药物组合物
CN114075123B (zh) 苄胺类衍生物及其制备方法与用途
CN102670572A (zh) 一种双-（2,3-二溴-4,5-二羟基苄基）醚的合成与应用
WO2015010666A2 (zh) 一种苯酚衍生物及其应用
CN102666528A (zh) 晶体cdc7 抑制剂盐
CN100569740C (zh) N-or酰胺类化合物,其制备方法和其应用
JPS6322069A (ja) 複素多環式芳香族化合物
RU2802964C2 (ru) Твердые формы 2-(5-(4-(2-морфолиноэтокси)фенил)пиридин-2-ил)-n-бензилацетамида
US4758591A (en) Dialkanoyloxybenzylidene dialkanoate
EP3722299A1 (en) Anti-pain compound and preparation method therefor
Bakar et al. Molecular Docking Study, Synthesis and Characterization of New Hybrid Anthracene-Thiophene Compounds with Chalcone and Pyridine Scaffolds
CN101759665A (zh) 取代苯基哌嗪芳烷醇衍生物及其在制备镇痛药物中的应用